2008, Manufacturing and Provider - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2008

Manufacturing

Provider

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

GeriPal

MAY 8, 2025

Alex 06:03 Is psilocybin that’s used for medicinal purposes in your studies, for example, is that manufactured or is it derived directly from mushrooms? Some of them also had psychiatric or psychosocial oncology providers as well. So I can say anything I want. I am not sticking my foot in my mouth. But these were people who were.

Illness

Illness IT Patient-Centered Patients

FDA-Approved Labeling: Is Enough Enough?

FDA Law

AUGUST 21, 2023

Recall that the funds provided under the Prescription Drug User Fee Acts (PDUFA) are not available to support the agency’s efforts related to monograph drugs.) This is because the presumption that manufacturers can unilaterally make substantive changes to the labeling of an OTC Monograph drug product is false.

Manufacturing

Manufacturing Consulting Healthcare Professional Vaccination

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

FDA-Approved Labeling: Is Enough Enough?

Stay Connected